Fourth International Drug-Drug Interaction (DDI) Workshop At Marbach Castle, Germany Will Take Place In May 2013

Online, November 28, 2012 (Newswire.com) - The organisation team of the International DDI Workshop presents the preliminary programme of the DDI 2013 - 4th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions, which will take place from May 26th to 28th 2013 at Marbach Castle, Germany.

In May/June 2010 the 1st International DDI Workshop at Marbach Castle was held based on the initiative of a group of international scientists and experts in the field from academia and industry. The event was triggered by the notion that the area of drug-drug interactions is getting increasingly important and complex in view of continuously emerging new therapies, complex treatment algorithms for many widespread disease states and ageing populations in the industrialized countries.

The 2010 workshop combined a regulatory update on the investigation of DDIs from the European Rapporteur perspective (MPA, Sweden) along with a scientific update focusing on the investigation of metabolism-and transporter-based DDIs. The 2011 workshop focused on large molecule DDIs, non-metabolic DDIs affecting drug absorption as well as complex DDIs in selected therapeutic areas such as oncology, cardiovascular disorders, as well as immunosuppressant and anti-infective therapies.

More than 80 experts from 14 countries attended the DDI Workshop 2012. The speakers came from 6 different countries (USA, Germany, Great Britain, Finland, Sweden, and New Zealand), thereof 5 from the US. They presented scientific news, the content of the draft guidelines and state of the art lectures. The scientific sessions covered different aspects to current regulatory issues, UGT-based DDIs, transporter-based DDIs and pharmacodynamic DDIs.

The DDI Workshop offers a unique opportunity for scientific exchange and networking across company and organizational borders, and to learn about the current state-of-the-art in the investigation of DDIs. Based on the detailed feedback received from the expert audience on additional areas of interest requiring future consideration, the structure and content of the DDI Workshop 2013 were designed. In 2013 the workshop will cover scientific sessions to drug interactions involving therapeutic biologics and anti-infective agents, clinical, epidemiological and pharmacovigilance aspects of DDIs, novel approaches to improve the prediction of DDIs and DDIs in special populations.
The preliminary programme of the DDI Workshop 2013 is now available on the website of cr.appliance.

About the DDI Workshop
The DDI Workshop is an initiative of cr.appliance in cooperation with Hartmut Derendorf, Amin Rostami-Hodjegan, and Oliver von Richter. The meeting will take place in Marbach Castle Conference Centre, located at the Lake Constance, Germany.
The organizers of the DDI Workshop are:
• Hartmut Derendorf, PhD FCP; College of Pharmacy, University of Florida, USA
• Robert Hermann, MD FCP; cr.appliance, Germany
• Amin Rostami-Hodjegan, PhD FCP; Faculty of Medical and Human Sciences, University of Manchester, UK
• Oliver von Richter, PhD FCP; Dept. Exploratory Medicine, Merck Serono, Germany